Cannabinoids

Cannabinoids has been studied in 13 papers since 2019: 1 observational study in people, 12 reviews; 8 in the past year. Its furthest trials in people are at phase 2. The newest paper, Oct 29, 2026: “The Effects of Cannabinoids in Cardiovascular Disease: A Comprehensive Review”.

Intervention Phase 2

13 papers study it143 more mention it4 findingsUpdated Oct 29, 2026

PubChem MeSH

7 new papers in 30 daysSee all 155 papers on cannabinoids

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country; 3 trials, none about aging.

“Memantine, opioids, cannabinoids, prior history of fall, female sex, advanced age and disease stage, chronic liver disease, diabetes, and chronic obstructive pulmonary disease all increased the hazard rate of falling.”

The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancerAmerican journal of epidemiology2024doi:10.1093/aje/kwae067

1 lab in 1 country
3 trials, none about aging

Funder: National Cancer Institute

Humans1

What did studies of cannabinoids find?

Studies of cannabinoids measured 3 outcomes: behavioral symptoms, oxidative stress and ROS signaling and inflammation.

Behavioral symptoms

upin humans1

1 study

Cannabinoids improve behavioral symptoms in humans.
“Cannabinoids improved behavioral symptoms but showed no measurable cognitive effects.”
Review
Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
NutrientsMar 12, 2026

Oxidative stress and ROS signaling

downin reviews1

1 study

Cannabinoids decrease oxidative stress and ROS signaling.
“cannabinoids, as components of the cannabinoid system (CS), have proven beneficial effects such as anti-inflammatory, immunomodulatory, neuromodulatory, antioxidative, and cardioprotective effects.”
Review
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
BiomedicinesOct 6, 2022

More on Oxidative stress and ROS signaling

Inflammation

downin reviews1

1 study

Cannabinoids decrease inflammation.
“cannabinoids, as components of the cannabinoid system (CS), have proven beneficial effects such as anti-inflammatory, immunomodulatory, neuromodulatory, antioxidative, and cardioprotective effects.”
Review
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
BiomedicinesOct 6, 2022

What is cannabinoids linked with?

Studies link cannabinoids with falls.

Falls

upin humans1

1 study

Cannabinoids are linked with a higher risk of falls in older patients with colorectal cancer.
“Memantine, opioids, cannabinoids, prior history of fall, female sex, advanced age and disease stage, chronic liver disease, diabetes, and chronic obstructive pulmonary disease all increased the hazard rate of falling.”
Humansin older patients with colorectal cancer
The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancer
American journal of epidemiologyMay 16, 2024